步速与COPD急性加重住院后不良结局的关系
本研究纳入213例因慢阻肺急性加重住院的患者,出院时进行4米步速测试,随访1年。结果显示步速每增加0.1 m·s-1,全因再入院和全因死亡风险均显著降低,且加入步速的模型判别能力优于年龄或FEV1占预计值百分比。
要点
- 出院时4米步速测试可识别慢阻肺急性加重后再入院和死亡高风险患者。
- 步速每增加0.1 m·s-1,全因再入院和全因死亡风险均显著下降。
- 含步速的模型对再入院和死亡的判别能力优于年龄或FEV1占预计值百分比。
核心结论
- 4米步速测试可简单识别慢阻肺急性加重出院后的高风险患者,为出院后照护计划提供信息。
研究设计与样本
- 研究纳入213例因慢阻肺急性加重住院的患者(52%男性,平均年龄72岁,平均FEV1占预计值35%),出院时记录4米步速和基线人口学特征,随访1年收集全因再入院和死亡,采用多变量Cox比例风险回归、Kaplan-Meier和竞争风险分析。
主要发现
- 随访期间111例(52%)再入院,35例(16%)死亡。
- 步速每增加0.1 m·s-1,全因再入院的调整亚分布风险比为0.868(95% CI 0.797-0.945;p=0.001)。
- 步速每增加0.1 m·s-1,全因死亡的调整亚分布风险比为0.747(95% CI 0.622-0.898;p=0.002)。
- 含4米步速的再入院和死亡模型ROC曲线下面积分别为0.73和0.80,判别能力高于年龄或FEV1占预计值百分比单独。
- Kaplan-Meier和竞争风险曲线显示步速较慢四分位组再入院和死亡时间更短(log-rank,均p<0.001)。
临床怎么用
- 对慢阻肺急性加重住院患者,出院时可考虑进行4米步速测试以辅助识别再入院和死亡高风险个体。
- 步速较慢的患者可能需要更积极的出院后照护计划和支持。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The 4-m gait speed (4MGS) test is a simple physical performance measure and surrogate marker of frailty that is associated with adverse outcomes in older adults. We aimed to assess the ability of 4MGS to predict prognosis in patients hospitalised with acute exacerbations of chronic obstructive pulmonary disease (AECOPD). METHODS: 213 participants hospitalised with AECOPD (52% male, mean age 72 years and mean forced expiratory volume in 1 s (FEV1) 35% predicted) were enrolled. 4MGS and baseline demographics were recorded at hospital discharge. All-cause readmission and mortality were collected for 1 year after discharge and multivariable Cox proportional hazards regressions were performed. Kaplan-Meier and competing risks analyses were conducted comparing time to all-cause readmission and mortality between 4MGS quartiles. RESULTS: 111 participants (52%) were readmitted and 35 (16%) died during the follow-up period. 4MGS was associated with all-cause readmission, with an adjusted subdistribution hazard ratio of 0.868 (95% CI 0.797-0.945; p=0.001) per 0.1 m·s-1 increase in gait speed, and with all-cause mortality, with an adjusted subdistribution hazard ratio of 0.747 (95% CI 0.622-0.898; p=0.002) per 0.1 m·s-1 increase in gait speed. Readmission and mortality models incorporating 4MGS had higher discrimination than age or FEV1 % pred alone, with areas under the receiver operator characteristic curves of 0.73 and 0.80, respectively. Kaplan-Meier and competing risks curves demonstrated that those in slower gait speed quartiles had reduced time to readmission and mortality (log-rank, both p<0.001). CONCLUSIONS: 4MGS provides a simple means of identifying at-risk patients with COPD at hospital discharge. This provides valuable information to plan post-discharge care and support.
引用
- Walsh JA, Barker RE, Kon SSC, et al. Gait speed and adverse outcomes following hospitalised exacerbation of COPD. Eur Respir J. 2021. PMID: 33926974. doi:10.1183/13993003.04047-2020
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。